Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
Androgen deprivation therapy remains a critical component of treatment for men with
advanced prostate cancer, and data support its use in metastatic disease and in conjunction …
advanced prostate cancer, and data support its use in metastatic disease and in conjunction …
Biochemical recurrence after radical prostatectomy: what does it mean?
R Tourinho-Barbosa, V Srougi, I Nunes-Silva… - International braz j …, 2018 - SciELO Brasil
Background Radical prostatectomy (RP) has been used as the main primary treatment for
prostate cancer (PCa) for many years with excellent oncologic results. However …
prostate cancer (PCa) for many years with excellent oncologic results. However …
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a …
Background How best to treat rising prostate-specific antigen (PSA) concentration after
radical prostatectomy is an urgent clinical question. Salvage radiotherapy delays the need …
radical prostatectomy is an urgent clinical question. Salvage radiotherapy delays the need …
68Ga-PSMA-11 PET/CT map** of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL: impact …
Target volume delineations for prostate cancer (PCa) salvage radiotherapy (SRT) after
radical prostatectomy are usually drawn in the absence of visibly recurrent disease. 68Ga …
radical prostatectomy are usually drawn in the absence of visibly recurrent disease. 68Ga …
Predicting 15-year prostate cancer specific mortality after radical prostatectomy
Purpose: Long-term prostate cancer specific mortality after radical prostatectomy is poorly
defined in the era of widespread screening. An understanding of the treated natural history …
defined in the era of widespread screening. An understanding of the treated natural history …
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized …
IM Thompson, CM Tangen, J Paradelo… - The Journal of …, 2009 - auajournals.org
Purpose: Extraprostatic disease will be manifest in a third of men after radical prostatectomy.
We present the long-term followup of a randomized clinical trial of radiotherapy to reduce the …
We present the long-term followup of a randomized clinical trial of radiotherapy to reduce the …
68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
Purpose To assess the association between PSA levels, PSA kinetics and other factors and
a pathological 68 Ga-PSMA PET/CT scan in patients with recurrent prostate cancer (rPCa) …
a pathological 68 Ga-PSMA PET/CT scan in patients with recurrent prostate cancer (rPCa) …
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
Purpose An increasing serum prostate-specific antigen (PSA) level is the initial sign of
recurrent prostate cancer among patients treated with radical prostatectomy. Salvage …
recurrent prostate cancer among patients treated with radical prostatectomy. Salvage …
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative …
T Wiegel, D Bottke, U Steiner, A Siegmann… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Local failure after radical prostatectomy (RP) is common in patients with cancer
extending beyond the capsule. Two randomized trials demonstrated an advantage for …
extending beyond the capsule. Two randomized trials demonstrated an advantage for …
[PDF][PDF] Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis
B Biki, E Mascha, DC Moriarty, JM Fitzpatrick… - …, 2008 - scholar.archive.org
Background: Regional anesthesia and analgesia attenuate or prevent perioperative factors
that favor minimal residual disease after removal of the primary carcinoma. Therefore, the …
that favor minimal residual disease after removal of the primary carcinoma. Therefore, the …